RxDoctor Payments Data

Anne Ford, MD

Family Medicine · Brea, CANPI 1518967140

Payments from drug & device makers

$328in general payments, 2019–2025

Across 16 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$134
  • Novartis$40
  • Pfizer$34
  • Abbott$24
  • Amgen$22
  • Hologic Sales And Service, LLC$21
  • plus $54 from 3 others

What the payments were for

  • Consulting fees$206%
  • Food & beverage$30994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$328 in reported general payments places this provider in the 55th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$112,119
Medicare patients
332
Services billed
1,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide135$154,762
EliquisApixaban139$136,616
JanuviaSitagliptin Phosphate33$47,145
MounjaroTirzepatide40$47,142
JardianceEmpagliflozin44$46,180
Breo ElliptaFluticasone/Vilanterol17$19,472
MyrbetriqMirabegron13$17,428
WegovySemaglutide13$16,417
JanumetSitagliptin Phos/Metformin Hcl15$11,367
SynthroidLevothyroxine Sodium117$10,574
PremarinEstrogens, Conjugated21$9,782
Levothyroxine Sodium703$9,279
LinzessLinaclotide11$8,436
AmbienZolpidem Tartrate12$7,539
Atorvastatin Calcium699$6,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$34$146,399160 claims
Boehringer IngelheimJardiance$14$46,18044 claims
GSKBreo Ellipta$134$19,47217 claims
Astellas Pharma US IncMyrbetriq$20$17,42813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 10,533 family medicine providers in California.

Other family medicine in Brea

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →